Management of COPD: Is there a role for quantitative imaging?

While the recent development of quantitative imaging methods have led to their increased use in the diagnosis and management of many chronic diseases, medical imaging still plays a limited role in the management of chronic obstructive pulmonary disease (COPD). In this review we highlight three pulmonary imaging modalities: computed tomography (CT), magnetic resonance imaging (MRI) and optical coherence tomography (OCT) imaging and the COPD biomarkers that may be helpful for managing COPD patients. We discussed the current role imaging plays in COPD management as well as the potential role quantitative imaging will play by identifying imaging phenotypes to enable more effective COPD management and improved outcomes.

[1]  Yasutaka Nakano,et al.  The prediction of small airway dimensions using computed tomography. , 2005, American journal of respiratory and critical care medicine.

[2]  Jan Wolber,et al.  Hyperpolarized 129Xe MR Imaging of Alveolar Gas Uptake in Humans , 2010, PloS one.

[3]  Grace Parraga,et al.  Ultra‐short echo‐time pulmonary MRI: Evaluation and reproducibility in COPD subjects with and without bronchiectasis , 2015, Journal of magnetic resonance imaging : JMRI.

[4]  J. Best,et al.  CT measurements of lung density in life can quantitate distal airspace enlargement--an essential defining feature of human emphysema. , 1988, The American review of respiratory disease.

[5]  J G Goldin,et al.  Development and testing of image-processing methods for the quantitative assessment of airway hyperresponsiveness from high-resolution CT images. , 1997, Journal of computer assisted tomography.

[6]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[7]  John P Mugler,et al.  Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge. , 2003, The Journal of allergy and clinical immunology.

[8]  F. Martinez,et al.  Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials , 2009, The Lancet.

[9]  E. Marchiori,et al.  Correlation between computed tomographic and magnetic resonance imaging findings of parenchymal lung diseases. , 2013, European journal of radiology.

[10]  John Connett,et al.  The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality , 2005, Annals of Internal Medicine.

[11]  David D Sampson,et al.  Elastic properties of the central airways in obstructive lung diseases measured using anatomical optical coherence tomography. , 2011, American journal of respiratory and critical care medicine.

[12]  Aaron Fenster,et al.  Globally optimal co-segmentation of three-dimensional pulmonary 1H and hyperpolarized 3He MRI with spatial consistence prior , 2015, Medical Image Anal..

[13]  Sang Joon Park,et al.  Chronic obstructive pulmonary disease: quantitative and visual ventilation pattern analysis at xenon ventilation CT performed by using a dual-energy technique. , 2010, Radiology.

[14]  Eric A. Hoffman,et al.  Accurate measurement of intrathoracic airways , 1997, IEEE Transactions on Medical Imaging.

[15]  Pierre Lane,et al.  Reproducibility of optical coherence tomography airway imaging. , 2015, Biomedical optics express.

[16]  R. Djukanović,et al.  Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD , 2004, Thorax.

[17]  D. Yablonskiy,et al.  Direct comparison of 129Xe diffusion measurements with quantitative histology in human lungs , 2017, Magnetic resonance in medicine.

[18]  P. Paré,et al.  Quantitative assessment of airway remodeling using high-resolution CT. , 2002, Chest.

[19]  R. Zuwallack,et al.  An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. , 2015, American journal of respiratory and critical care medicine.

[20]  Y. Ohno,et al.  T2* measurements of 3-T MRI with ultrashort TEs: capabilities of pulmonary function assessment and clinical stage classification in smokers. , 2011, AJR. American journal of roentgenology.

[21]  Joon Beom Seo,et al.  Assessment of Regional Xenon Ventilation, Perfusion, and Ventilation-Perfusion Mismatch Using Dual-Energy Computed Tomography in Chronic Obstructive Pulmonary Disease Patients , 2015, Investigative radiology.

[22]  G. Parker,et al.  COPD Patients Have Short Lung Magnetic Resonance T1 Relaxation Time , 2016, COPD.

[23]  V M Mai,et al.  Perfusion imaging of the human lung using flow-sensitive alternating inversion recovery with an extra radiofrequency pulse (FAIRER). , 1999, Magnetic resonance imaging.

[24]  K. Murase,et al.  Assessment of bolus injection protocol with appropriate concentration for quantitative assessment of pulmonary perfusion by dynamic contrast‐enhanced MR imaging , 2007, Journal of magnetic resonance imaging : JMRI.

[25]  Eric A. Hoffman,et al.  Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS). , 2015, Academic radiology.

[26]  John P Mugler,et al.  Feature analysis of hyperpolarized helium‐3 pulmonary MRI: A study of asthmatics versus nonasthmatics , 2010, Magnetic resonance in medicine.

[27]  Sang Min Lee,et al.  Detailed analysis of the density change on chest CT of COPD using non-rigid registration of inspiration/expiration CT scans , 2015, European Radiology.

[28]  A A Bankier,et al.  Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry. , 1999, Radiology.

[29]  Ella A. Kazerooni,et al.  CT-based Biomarker Provides Unique Signature for Diagnosis of COPD Phenotypes and Disease Progression , 2012, Nature Medicine.

[30]  Raúl San José Estépar,et al.  A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes. , 2015, American journal of respiratory and critical care medicine.

[31]  E. Hoffman,et al.  High-resolution Computed Tomography Imaging of Airway Disease in Infants with Cystic , 2002 .

[32]  H. Kauczor,et al.  Oxygen-Enhanced Magnetic Resonance Imaging: Influence of Different Gas Delivery Methods on the T1-changes of the Lungs , 2008, Investigative radiology.

[33]  F. Martinez,et al.  Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials , 2009, The Lancet.

[34]  R. Holle,et al.  The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. , 2016, Respiratory medicine.

[35]  Miranda Kirby,et al.  Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease. , 2014, Radiology.

[36]  J. Seo,et al.  Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. , 2010, Respiratory medicine.

[37]  D. Hansell,et al.  Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (BeLieVeR-HIFi) , 2014 .

[38]  Bertram J Jobst,et al.  Functional Lung MRI in Chronic Obstructive Pulmonary Disease: Comparison of T1 Mapping, Oxygen-Enhanced T1 Mapping and Dynamic Contrast Enhanced Perfusion , 2015, PloS one.

[39]  B. Make,et al.  Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. , 2010, Chest.

[40]  Stephen Lam,et al.  Airway wall thickness assessed using computed tomography and optical coherence tomography. , 2008, American journal of respiratory and critical care medicine.

[41]  Robert R. Edelman,et al.  Noninvasive assessment of regional ventilation in the human lung using oxygen–enhanced magnetic resonance imaging , 1996, Nature Medicine.

[42]  J M Wild,et al.  Functional magnetic resonance imaging of the lung. , 2003, British journal of anaesthesia.

[43]  W. M. Foster,et al.  Perfluoropropane gas as a magnetic resonance lung imaging contrast agent in humans. , 2013, Chest.

[44]  M. Puderbach,et al.  MRI of the lung (1/3): methods , 2012, Insights into Imaging.

[45]  Grace Parraga,et al.  Free-breathing pulmonary 1H and Hyperpolarized 3He MRI: comparison in COPD and bronchiectasis. , 2015, Academic radiology.

[46]  Lisa M LaVange,et al.  Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) , 2013, Thorax.

[47]  Michael Deimling,et al.  Non‐contrast‐enhanced perfusion and ventilation assessment of the human lung by means of fourier decomposition in proton MRI , 2009, Magnetic resonance in medicine.

[48]  B. McManus,et al.  Ten-Year Trends in Direct Costs of COPD: A Population-Based Study. , 2015, Chest.

[49]  N L Müller,et al.  MR imaging of the lungs: value of short TE spin-echo pulse sequences. , 1992, AJR. American journal of roentgenology.

[50]  A. Chuchalin,et al.  A review of national guidelines for management of COPD in Europe , 2016, European Respiratory Journal.

[51]  G. Parraga,et al.  Hyperpolarized 129Xe magnetic resonance imaging: tolerability in healthy volunteers and subjects with pulmonary disease. , 2012, Academic radiology.

[52]  J. Hogg,et al.  Site and nature of airway obstruction in chronic obstructive lung disease. , 1968, The New England journal of medicine.

[53]  Lene Theil Skovgaard,et al.  Progress of emphysema in severe α1-Antitrypsin Deficiency as Assessed by Annual CT , 1997 .

[54]  W. MacNee,et al.  Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.

[55]  A. Gulsvik,et al.  Mortality by level of emphysema and airway wall thickness. , 2013, American journal of respiratory and critical care medicine.

[56]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[57]  Sean Keenan,et al.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. , 2007, Canadian respiratory journal.

[58]  Namkug Kim,et al.  A Pilot Trial on Pulmonary Emphysema Quantification and Perfusion Mapping in a Single-Step Using Contrast-Enhanced Dual-Energy Computed Tomography , 2012, Investigative radiology.

[59]  H. Kauczor,et al.  Improved visualization of delayed perfusion in lung MRI. , 2011, European journal of radiology.

[60]  J. Clausen,et al.  Quantitation of emphysema with three-dimensional CT densitometry: comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results. , 1999, Radiology.

[61]  Nicola A Hanania,et al.  Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. , 2011, Radiology.

[62]  Pierre Lane,et al.  Bronchial thermoplasty in asthma: 2-year follow-up using optical coherence tomography , 2014, European Respiratory Journal.

[63]  Kunihiro Yagihashi,et al.  Quantitative assessment of air trapping in chronic obstructive pulmonary disease using inspiratory and expiratory volumetric MDCT. , 2008, AJR. American journal of roentgenology.

[64]  J. Roos,et al.  Measuring diffusion limitation with a perfusion-limited gas--hyperpolarized 129Xe gas-transfer spectroscopy in patients with idiopathic pulmonary fibrosis. , 2014, Journal of applied physiology.

[65]  Annette Kopp-Schneider,et al.  Validation of Fourier decomposition MRI with dynamic contrast-enhanced MRI using visual and automated scoring of pulmonary perfusion in young cystic fibrosis patients. , 2013, European journal of radiology.

[66]  W. Happer,et al.  Biological magnetic resonance imaging using laser-polarized 129Xe , 1994, Nature.

[67]  K P Whittall,et al.  An analysis algorithm for measuring airway lumen and wall areas from high-resolution computed tomographic data. , 2000, American journal of respiratory and critical care medicine.

[68]  C. Heussel,et al.  Functional Magnetic Resonance Imaging of the Lung , 2014, Seminars in Respiratory and Critical Care Medicine.

[69]  P De Vuyst,et al.  Comparison of computed density and macroscopic morphometry in pulmonary emphysema. , 1995, American journal of respiratory and critical care medicine.

[70]  K. Kubo,et al.  The relations between expiratory chest CT using helical CT and pulmonary function tests in emphysema. , 1997, American journal of respiratory and critical care medicine.

[71]  M. Polkey,et al.  Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (The BeLieVeR-HIFi trial): study design and rationale , 2014, Thorax.

[72]  B Suki,et al.  Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[73]  René Werner,et al.  Regional Lung Ventilation Analysis Using Temporally Resolved Magnetic Resonance Imaging , 2016, Journal of computer assisted tomography.

[74]  H. Kauczor,et al.  Volumetry of Ventilated Airspaces by 3He MRI: Preliminary Results , 2001, Investigative radiology.

[75]  Hiroto Hatabu,et al.  Hyperpolarized (129)Xe MRI: a viable functional lung imaging modality? , 2007, European journal of radiology.

[76]  Hiroto Hatabu,et al.  Dynamic oxygen‐enhanced MRI reflects diffusing capacity of the lung , 2002, Magnetic resonance in medicine.

[77]  Benjamin M. Smith,et al.  Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) , 2014, Thorax.

[78]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[79]  A. Bankier,et al.  T1 mapping of the entire lung parenchyma: Influence of respiratory phase and correlation to lung function test results in patients with diffuse lung disease , 2008, Magnetic resonance in medicine.

[80]  J. Gieseke,et al.  Lung MRI at 3.0 T: a comparison of helical CT and high-field MRI in the detection of diffuse lung disease , 2005, European Radiology.

[81]  Meilan K. Han,et al.  Pulmonary arterial enlargement and acute exacerbations of COPD. , 2012, The New England journal of medicine.

[82]  Dmitriy A Yablonskiy,et al.  Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema , 2006, Magnetic resonance in medicine.

[83]  D. O’Donnell,et al.  Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[84]  Raúl San José Estépar,et al.  Genome-wide association identifies regulatory Loci associated with distinct local histogram emphysema patterns. , 2014, American journal of respiratory and critical care medicine.

[85]  Meilan K. Han,et al.  Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease. , 2016, American journal of respiratory and critical care medicine.

[86]  H. Kauczor,et al.  In vivo Gd-DTPA concentration for MR lung perfusion measurements: Assessment with computed tomography in a porcine model , 2008, European Radiology.

[87]  R. Günther,et al.  Feasibility of Pulmonary Ventilation Visualization With Aerosolized Magnetic Resonance Contrast Media , 2005, Investigative radiology.

[88]  W. Webb,et al.  Air trapping on expiratory high-resolution CT scans in the absence of inspiratory scan abnormalities: correlation with pulmonary function tests and differential diagnosis. , 1998, AJR. American journal of roentgenology.

[89]  T. Pilgram,et al.  Hyperpolarized 3He MR imaging: physiologic monitoring observations and safety considerations in 100 consecutive subjects. , 2008, Radiology.

[90]  L. Edwards,et al.  Changes in forced expiratory volume in 1 second over time in COPD. , 2011, The New England journal of medicine.

[91]  N. Müller,et al.  "Density mask". An objective method to quantitate emphysema using computed tomography. , 1988, Chest.

[92]  Suzanne C. Whiteman,et al.  Optical Coherence Tomography: Real-time Imaging of Bronchial Airways Microstructure and Detection of Inflammatory/Neoplastic Morphologic Changes , 2006, Clinical Cancer Research.

[93]  Aaron Fenster,et al.  Hyperpolarized 3He Ventilation Defects and Apparent Diffusion Coefficients in Chronic Obstructive Pulmonary Disease: Preliminary Results at 3.0 Tesla , 2007, Investigative radiology.

[94]  Miranda Kirby,et al.  Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps. , 2016, Radiology.

[95]  L. Edwards,et al.  Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. , 2011, Academic radiology.

[96]  Volker Rasche,et al.  Three‐dimensional accurate detection of lung emphysema in rats using ultra‐short and zero echo time MRI , 2015, NMR in biomedicine.

[97]  Joon Beom Seo,et al.  Xenon ventilation CT with a dual-energy technique of dual-source CT: initial experience. , 2008, Radiology.

[98]  M. Puderbach,et al.  MRI of the lung (2/3). Why … when … how? , 2012, Insights into Imaging.

[99]  Calum MacAulay,et al.  In vivo Optical Coherence Tomography Imaging of Preinvasive Bronchial Lesions , 2008, Clinical Cancer Research.

[100]  Raúl San José Estépar,et al.  Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD. , 2010, Respiratory medicine.

[101]  Miranda Kirby,et al.  Hyperpolarized 3He magnetic resonance functional imaging semiautomated segmentation. , 2012, Academic radiology.

[102]  A. Gulsvik,et al.  Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking , 2009, European Respiratory Journal.

[103]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.